Method for quantifying adeno-associated virus
US-2016273058-A1 · Sep 22, 2016 · US
US10415020B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10415020-B2 |
| Application number | US-201615540606-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 8, 2016 |
| Priority date | Jan 9, 2015 |
| Publication date | Sep 17, 2019 |
| Grant date | Sep 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a method for producing non-enveloped viral particles, comprising a step for obtaining a fraction containing non-enveloped viral particles by removing precipitates which are produced in a step for adding a substance which reduces the solubility of proteins under acidic conditions and/or a substance which precipitates under acidic conditions to a neutral or basic sample containing non-enveloped viral particles, and acidifying the sample after the addition of the substance.
Opening claim text (preview).
The invention claimed is: 1. A method of producing a non-enveloped virus particle, the method comprising: (a) a step of adding a carboxylic acid type anionic surfactant to a neutral or basic sample containing a non-enveloped virus particle, (b) a step of acidifying the sample to which the surfactant is added to form a precipitate, (c) a step of removing a precipitate formed in step (b) to obtain a supernatant fraction containing the non-enveloped virus particle, wherein the non-enveloped virus particle is adeno-associated virus particle. 2. The method according to claim 1 , which further comprises (d) a step of purifying the non-enveloped virus after step (c). 3. The method according to claim 1 , wherein the carboxylic acid type anionic surfactant is selected from the group consisting of sodium deoxycholate, sodium chenodeoxycholate, sodium cholate, sodium glycocholate, sodium taurocholate, and sodium taurodeoxycholate. 4. The method according to claim 1 , wherein the step of acidifying is a step of adding an acidic solution. 5. The method according to claim 1 , wherein the neutral or basic sample containing a non-enveloped virus particle is a lysate or a homogenate of a non-enveloped virus-producing cell, a culture supernatant of a non-enveloped virus-producing cell which contains a non-enveloped virus particle, or an extract obtained from a non-enveloped virus-producing cell. 6. The method according to claim 5 , wherein the neutral or basic sample containing a non-enveloped virus particle is a sample obtained by bringing a non-enveloped virus-producing cell into contact with an acidic solution and then adjusting to a neutral or basic pH. 7. The method according to claim 1 , wherein the neutral or basic sample containing a non-enveloped virus particle is a sample treated with nuclease. 8. A kit for performing the method according to claim 1 , comprising: (1) a carboxylic acid type anionic surfactant, and (2) an acidic solution. 9. The kit according to claim 8 , which further comprises a neutralizing solution.
Recombinant DNA-technology · CPC title
Recovery or purification · CPC title
Cells modified by introduction of foreign genetic material · CPC title
Adenoviridae · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.